botiss biomaterials published an expert talk discussing soft tissue thickness and soft tissue augmentation in immediate implant placement.
Published
Signal category
Research & Knowledge
Quote
“As discussed in this reel, most patients naturally do not present with the ~2 mm soft tissue thickness desired around an implant-supported restoration in the aesthetic zone.”
— botiss biomaterials team
Company
botiss biomaterials
The future in regeneration is now.
- Industry
- Pharmaceutical Manufacturing
- Location
- Zossen b. Berlin, DE
- Company size
- 71 employees
botiss biomaterials is one of the leading companies in the field of dental bone and tissue regeneration. The botiss regeneration system is available in over 100 countries worldwide via a global network of distribution partners and employees, who are committed experts in the field of oral surgery and implantology. The products of the botiss regeneration system have proven their success in terms of safety, efficacy, and reliability in a multitude of preclinical and clinical studies and, most importantly, in the daily clinical work, with hundreds of thousands of patients worldwide. We substantially invest in RESEARCH and EDUCATION. Unique innovations, such as mucoderm®, maxgraft® bonebuilder, and cerabone® plus, the concept of high-quality learning and education with the botiss academy, and our international bone & tissue days are the results of our partnership with worldwide renowned academic research institutes, global opinion leaders, and practitioners in their daily clinical environment.
Founded 2009